{
  "disease_name": "PGM3-CDG",
  "orpha_code": "443811",
  "drugs": [
    {
      "name": "DEQSIGA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/700589?name=443811&mode=orpha&region=",
      "regulatory_id": "700589",
      "orpha_substance_code": "ORPHA:101997",
      "details": [
        "DEQSIGA(Tradename                        - 02/05/2025)Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:2103 Guillain-Barré syndromeORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:641 Multifocal motor neuropathyORPHA:101997 Primary immunodeficiency",
        "DEQSIGA(Tradename                        - 02/05/2025)",
        "(Tradename                        - 02/05/2025)",
        "Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:2103 Guillain-Barré syndromeORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:641 Multifocal motor neuropathyORPHA:101997 Primary immunodeficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/700586?name=443811&mode=orpha&region=&status=all",
          "text": "DEQSIGA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/3002",
          "text": "ORPHA:3002 Immune thrombocytopenia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2331",
          "text": "ORPHA:2331 Kawasaki disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2103",
          "text": "ORPHA:2103 Guillain-Barré syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2932",
          "text": "ORPHA:2932 Chronic inflammatory demyelinating polyneuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/641",
          "text": "ORPHA:641 Multifocal motor neuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101997",
          "text": "ORPHA:101997 Primary immunodeficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/700589?name=443811&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:2103 Guillain-Barré syndrome\n                                \n\n\n\n\n                                    ORPHA:2932 Chronic inflammatory demyelinating polyneuropathy\n                                \n\n\n\n\n                                    ORPHA:641 Multifocal motor neuropathy\n                                \n\n\n\n\n                                    ORPHA:101997 Primary immunodeficiency\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T05:59:39.608282",
  "run_number": 1,
  "total_drugs_found": 1,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=PGM3-CDG&orphaCode=443811&name=443811&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "PGM3-CDG",
    "orphaCode": "443811",
    "name": "443811",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}